Racoon Pharmaceutical
Cinnarizine (20mg) + Dimenhydrinate (40mg)
Dizimax Tablet is used to treat vertigo, a combination medicine that acts by relaxing vascular smooth muscles of the blood vessels of the ear and improves blood circulation.
Tablet
Dizimax Tablet should be taken with food to avoid stomach upset. Take this medicine as advised by your doctor and preferably at a fixed time each day. Do not skip any doses but if you miss a dose of this medicine, take it as soon as you remember. Finish the full course of treatment and never stop this medicine suddenly without talking to your doctor.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Dizimax Tablet is to be taken with food.
No common side effects listed.
Dizimax Tablet may cause excessive drowsiness with alcohol.
Information regarding the use of Dizimax Tablet during breastfeeding is not available. Please consult your doctor.
Dizimax Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Dizimax Tablet is a combination of two medicines: Cinnarizine and Dimenhydrinate. Cinnarizine is a calcium channel antagonist which works by preventing constriction of the blood vessels of the inner ear. This improves the microcirculation of the ear. Dimenhydrinate is an antiallergic. It blocks the action of a chemical messenger (histamine) that is responsible for light-headedness in vertigo.
Take it with food to avoid stomach upset. It may cause dizziness and sleepiness. Do not drive or do anything that requires mental focus until you know how this medicine affects you. Do not drink alcohol while taking this medicine as it may cause increased sleepiness. Do not take this medicine if you are pregnant or breastfeeding. Do not stop taking Dizimax Tablet without talking to your doctor first.